A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.
Grantová podpora
P01 CA087969
NCI NIH HHS - United States
HHSN268201100004I
NHLBI NIH HHS - United States
CA098122
NCI NIH HHS - United States
UM1 CA167552
NCI NIH HHS - United States
UL1 TR000430
NCATS NIH HHS - United States
CA167552
NCI NIH HHS - United States
N01 PC067009
NCI NIH HHS - United States
N02-PC-71105
NCI NIH HHS - United States
HHSN268201100001I
NHLBI NIH HHS - United States
N01-RC-45035
CCR NIH HHS - United States
P30 CA016672
NCI NIH HHS - United States
P30 CA016087
NCI NIH HHS - United States
HHSN261201000140C
NCI NIH HHS - United States
CA97274
NCI NIH HHS - United States
N01 PC067010
NCI NIH HHS - United States
R01 CA098122
NCI NIH HHS - United States
U01 HG007033
NHGRI NIH HHS - United States
K07 CA115687
NCI NIH HHS - United States
CA098566
NCI NIH HHS - United States
R21 CA178800
NCI NIH HHS - United States
HHSN268201100046C
NHLBI NIH HHS - United States
CIHR - Canada
UM1 CA182934
NCI NIH HHS - United States
U01 CA167552
NCI NIH HHS - United States
CA87969
NCI NIH HHS - United States
N01 PC067008
NCI NIH HHS - United States
HHSN268201100003C
WHI NIH HHS - United States
CA49449
NCI NIH HHS - United States
R01CA154643
NCI NIH HHS - United States
P30 ES000260
NIEHS NIH HHS - United States
P30 CA008748
NCI NIH HHS - United States
R01 CA129539
NCI NIH HHS - United States
R25 CA098566
NCI NIH HHS - United States
U58 DP000807
NCCDPHP CDC HHS - United States
N01-PC-67009
NCI NIH HHS - United States
CA149445
NCI NIH HHS - United States
R01 CA154643
NCI NIH HHS - United States
R01 CA062006
NCI NIH HHS - United States
N01 PC065064
NCI NIH HHS - United States
UL1 TR000135
NCATS NIH HHS - United States
HHSN271201100004C
NIA NIH HHS - United States
R01 CA098661
NCI NIH HHS - United States
R01CA1046282
NCI NIH HHS - United States
N01 CO012400
NCI NIH HHS - United States
HHSN268201100002C
WHI NIH HHS - United States
P30 CA015083
NCI NIH HHS - United States
R01 CA092153
NCI NIH HHS - United States
HHSN261201000035I
NCI NIH HHS - United States
UL1 TR000142
NCATS NIH HHS - United States
Intramural NIH HHS - United States
5R01 CA69669-02
NCI NIH HHS - United States
HHSN261201000035C
NCI NIH HHS - United States
HHSN261201000034C
NCI NIH HHS - United States
P30 CA033572
NCI NIH HHS - United States
N01 RC037004
CCR NIH HHS - United States
P50 CA097274
NCI NIH HHS - United States
HHSN268201100003I
NHLBI NIH HHS - United States
R01 CA049449
NCI NIH HHS - United States
HHSN268201100002I
NHLBI NIH HHS - United States
N01 CN045165
NCI NIH HHS - United States
U01 CA049449
NCI NIH HHS - United States
R01 CA149445
NCI NIH HHS - United States
001
World Health Organization - International
#1U58 DP000807-01
NCCDPHP CDC HHS - United States
P50 CA97274
NCI NIH HHS - United States
HHSN268201100001C
WHI NIH HHS - United States
HHSN268201100004C
WHI NIH HHS - United States
ES000260
NIEHS NIH HHS - United States
PubMed
25569183
PubMed Central
PMC4287989
DOI
10.1038/ncomms6751
PII: ncomms6751
Knihovny.cz E-zdroje
- MeSH
- běloši genetika MeSH
- butyrofiliny MeSH
- celogenomová asociační studie MeSH
- genotyp MeSH
- hlavní histokompatibilní komplex genetika MeSH
- jednonukleotidový polymorfismus genetika MeSH
- lidé MeSH
- lymfom z B-buněk marginální zóny genetika MeSH
- membránové glykoproteiny genetika MeSH
- výpočetní biologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, N.I.H., Intramural MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Názvy látek
- BTNL2 protein, human MeSH Prohlížeč
- butyrofiliny MeSH
- membránové glykoproteiny MeSH
Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. This is the first evidence that genetic variation in the major histocompatibility complex influences MZL susceptibility.
] Unit of Infections and Cancer Barcelona 8036 Spain
Center For Chronic Immunodeficiency University Medical Center Freiburg Freiburg 79108 Germany
Department of Biomedical Science University of Cagliari Monserrato Cagliari 09042 Italy
Department of Biostatistics Yale School of Public Health New Haven Connecticut 06520 USA
Department of Cancer Etiology City of Hope Beckman Research Institute Duarte California 91030 USA
Department of Epidemiology Harvard School of Public Health Boston Massachusetts 02115 USA
Department of Epidemiology M D Anderson Cancer Center Houston Texas 77030 USA
Department of Health Sciences Research Mayo Clinic Rochester Minnesota 55905 USA
Department of Health Sciences University of York York YO10 5DD UK
Department of Health Studies University of Chicago Chicago Illinois 60637 USA
Department of Medicine Mayo Clinic Rochester Minnesota 55905 USA
Department of Medicine Memorial Sloan Kettering Cancer Center New York New York 10065 USA
Department of Medicine Solna Karolinska Institutet Stockholm 17176 Sweden
Department of Pathological Anatomy University of Bari Bari 70124 Italy
Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland 20892 USA
Division of Cancer Epidemiology German Cancer Research Center Heidelberg 69120 Germany
Division of Endocrinology Diabetes and Metabolism The Ohio State University Columbus Ohio 43210 USA
Epidemiology Research Program American Cancer Society Atlanta Georgia 30303 USA
Health Studies Sector Westat Rockville Maryland 20850 USA
Interdisciplinary Department of Medicine University of Bari Bari 70124 Italy
Prince of Wales Clinical School University of New South Wales Sydney New South Wales 2052 Australia
School of Nursing and Human Sciences Dublin City University Dublin 9 Ireland
Sydney School of Public Health The University of Sydney Sydney New South Wales 2006 Australia
The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York 10029 USA
Zobrazit více v PubMed
Doglioni C., Wotherspoon A. C., Moschini A., de Boni M. & Isaacson P. G. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339, 834–835 (1992). PubMed
Parsonnet J. PubMed
Ku D. H. PubMed
Mayerle J. PubMed
Arnett H. A. PubMed
Nguyen T., Liu X. K., Zhang Y. & Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J. Immunol. 176, 7354–7360 (2006). PubMed PMC
Swanson R. M. PubMed
Hystad M. E. PubMed
Dias C. & Isenberg D. A. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nat. Rev. Rheumatol. 7, 360–368 (2011). PubMed
Swerdlow S., Campo E. & Harris N. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues IARC Press (2008).
Pritchard J. K., Stephens M. & Donnelly P. Inference of population structure using multilocus genotype data. Genetics 155, 945–959 (2000). PubMed PMC
Price A. L. PubMed
Howie B. N., Donnelly P. & Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009). PubMed PMC
Ferreira T. & Marchini J. Modeling interactions with known risk loci-a Bayesian model averaging approach. Ann. Hum. Genet. 75, 1–9 (2011). PubMed
Dixon A. L. PubMed
Chen W. M. & Abecasis G. R. Family-based association tests for genomewide association scans. Am. J. Hum. Genet. 81, 913–926 (2007). PubMed PMC
Abecasis G. R. & Wigginton J. E. Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. Am. J. Hum. Genet. 77, 754–767 (2005). PubMed PMC
Barenboim M. & Manke T. ChroMoS: an integrated web tool for SNP classification, prioritization and functional interpretation. Bioinformatics 29, 2197–2198 (2013). PubMed PMC
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes
Genetically Determined Height and Risk of Non-hodgkin Lymphoma